Christopher J. Kirk, President and CSO at Kezar Life Sciences, Inc. (KZR), bought 76,922 shares at $2.60 ($200K) on 2020-02-04, disclosed to the SEC on 2020-02-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.60 | 38,461 | $100K | 50.0% |
| 2 | $2.60 | 38,461 | $100K | 50.0% |
| Total | $2.60 avg | 76,922 | $200K | 100% |
| Filing → |